Posted Aug. 9, 2012 at 9:08 a.m.

Premium Lock Salix pays $10M upfront for possible treatment of Crohn's Disease

Published: 2012-08-09 09:08:06
Updated: 2012-08-09 09:08:06

Salix Salix Pharmaceuticals announced on Monday a 62 percent increase in its first quarter revenue for 2012.

The Raleigh-based pharmaceutical firm licenses rights to an extended release version of the drug Rifaximin that targets gastrointestinal and respiratory ailments....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2014 WRAL TechWire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Dr. Mike Walden
Tech economy
Vivek Wadhwa
Commentary
Frank Vinluan
Life science
Scroll